OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| KIDS | ORTHOPEDIATRICS CORP | 2025-10-16 15:24:05 | 17.46 | -0.34 | -1.91 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KIDS | 0001425450 | ORTHOPEDIATRICS CORP | US68752L1008 | 5493000KUTPFGOPAT717 | 261761833 | Nasdaq | 3841 | Surgical & Medical Instruments & Apparatus | 1231 | — | 2850 FRONTIER DRIVE | WARSAW | IN | 46582 | UNITED STATES | US | 574-268-6379 | 2850 FRONTIER DRIVE, WARSAW, IN, 46582 | 2850 FRONTIER DRIVE, WARSAW, IN, 46582 | — | — | 2006 | — | — | — | 263,400,000 | 25,072,502 | 25,073,602 | OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana. | 2025-10-10 21:49:04 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 263,400,000 | -181,700,000 | -40.8223 | 24,286,590 | 737,094 | 3.13 |
| 2023 | 445,100,000 | -26,400,000 | -5.5992 | 23,549,496 | 556,050 | 2.4183 |
| 2022 | 471,500,000 | -223,800,000 | -32.1875 | 22,993,446 | 3,248,098 | 16.4499 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Gregory A. Odle | President | 2024 | 368,000 | — | 1,040,050 | 179,755 | 13,187 | 1,600,992 |
| Daniel J. Gerritzen | Secretary, Executive Vice President, General Counsel | 2024 | 368,000 | — | 1,040,050 | 179,755 | 12,153 | 1,599,958 |
| David R. Bailey | Chief Executive Officer, President | 2024 | 550,000 | — | 2,693,771 | 402,984 | 10,133 | 3,656,888 |
| Fred L. Hite | Chief Financial Officer, Chief Operating Officer | 2024 | 501,000 | — | 1,699,136 | 367,082 | 13,800 | 2,581,018 |
| Joseph W. Hauser | President | 2024 | 400,000 | — | 1,130,493 | 195,386 | 13,800 | 1,739,679 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 562 |
| 2023 | 247 |
| 2022 | 203 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 204,727,000 | 148,732,000 | 122,289,000 |
| Cost Of Revenue | 56,129,000 | 37,479,000 | 31,629,000 |
| Gross Profit | 148,598,000 | 111,253,000 | 90,660,000 |
| Research And Development Expenses | 11,034,000 | 10,196,000 | 8,014,000 |
| General And Administrative Expenses | 102,789,000 | 75,421,000 | 59,383,000 |
| Operating Expenses | 183,608,000 | 138,004,000 | 116,059,000 |
| Operating Income | -35,010,000 | -26,751,000 | -25,399,000 |
| Net Income | -37,822,000 | -20,974,000 | 1,258,000 |
| Earnings Per Share Basic | -1.64 | -0.92 | 0.06 |
| Earnings Per Share Diluted | -1.64 | -0.92 | 0.06 |
| Weighted Average Shares Outstanding Basic | 23,077,704 | 22,675,477 | 20,704,556 |
| Weighted Average Shares Outstanding Diluted | 23,077,704 | 22,675,477 | 20,947,727 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 43,820,000 | 31,055,000 | 10,462,000 |
| Marketable Securities Current | 25,013,000 | 49,251,000 | 109,299,000 |
| Accounts Receivable | 42,357,000 | 34,617,000 | 24,800,000 |
| Inventories | 117,005,000 | 105,851,000 | 78,192,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 237,173,000 | 226,496,000 | 226,719,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 50,596,000 | 41,048,000 | 34,286,000 |
| Other Assets Non Current | 10,417,000 | 2,940,000 | 14,921,000 |
| Total Assets Non Current | 236,036,000 | 212,249,000 | 201,008,000 |
| Total Assets | 473,209,000 | 438,745,000 | 427,727,000 |
| Accounts Payable | 8,908,000 | 12,649,000 | 11,150,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 897,000 | 152,000 | 144,000 |
| Other Liabilities Current | 9,659,000 | 7,391,000 | 5,018,000 |
| Total Liabilities Current | 33,962,000 | 41,666,000 | 30,871,000 |
| Long Term Debt | 77,483,000 | 11,063,000 | 907,000 |
| Other Liabilities Non Current | 5,892,000 | 1,112,000 | 492,000 |
| Total Liabilities Non Current | 84,681,000 | 20,054,000 | 18,208,000 |
| Total Liabilities | 118,643,000 | 61,720,000 | 49,079,000 |
| Common Stock | 6,000 | 6,000 | 6,000 |
| Retained Earnings | -235,564,000 | -197,742,000 | -176,768,000 |
| Accumulated Other Comprehensive Income | -10,773,000 | -5,526,000 | -5,400,000 |
| Total Shareholders Equity | 354,566,000 | 377,025,000 | 378,648,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 19,080,000 | 17,385,000 | 13,099,000 |
| Share Based Compensation Expense | 13,548,000 | 10,526,000 | 6,679,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 4,749,000 | 9,724,000 | 3,983,000 |
| Change In Inventories | 13,197,000 | 26,279,000 | 16,938,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -4,280,000 | 1,491,000 | -209,000 |
| Change In Other Liabilities | -315,000 | 4,631,000 | -536,000 |
| Cash From Operating Activities | -27,048,000 | -27,046,000 | -21,766,000 |
| Purchases Of Marketable Securities | 25,000,000 | 48,600,000 | 110,122,000 |
| Sales Of Marketable Securities | 49,855,000 | 112,904,000 | 46,872,000 |
| Acquisition Of Property Plant And Equipment | 14,263,000 | 16,878,000 | 10,031,000 |
| Acquisition Of Business | 20,225,000 | 0 | 8,360,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -13,162,000 | 41,677,000 | -113,371,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 0 | 0 | 139,282,000 |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | — | 0 | 31,000,000 |
| Repayment Of Long Term Debt | 16,000 | 16,000 | 16,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 53,135,000 | 7,301,000 | 135,974,000 |
| Change In Cash | 12,750,000 | 22,565,000 | 1,456,000 |
| Cash At End Of Period | 43,820,000 | 31,055,000 | 10,462,000 |
| Income Taxes Paid | — | — | — |
| Interest Paid | 2,752,000 | 42,000 | 700,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | -1.64 | -0.92 | 0.06 |
| Price To Earnings Ratio | -14.1341 | -35.337 | 662.1667 |
| Earnings Growth Rate | 78.2609 | -1,633.3333 | -107.1429 |
| Price Earnings To Growth Ratio | -0.1806 | 0.0216 | -6.1802 |
| Book Value Per Share | 15.364 | 16.627 | 18.2881 |
| Price To Book Ratio | 1.5087 | 1.9553 | 2.1724 |
| Ebitda | -18,707,000 | -3,547,000 | 11,933,000 |
| Enterprise Value | 569,501,178.72 | 717,339,757.27 | 813,181,009.88 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.2211 | 0.0297 | 0.0028 |
| Capital Expenditures | 28,628,000 | 24,147,000 | 18,870,000 |
| Free Cash Flow | -55,676,000 | -51,193,000 | -40,636,000 |
| Return On Equity | -0.1067 | -0.0556 | 0.0033 |
| One Year Beta | 1.1466 | 1.5132 | 1.2874 |
| Three Year Beta | 1.2931 | 1.2383 | 1.0317 |
| Five Year Beta | 1.0744 | 1.0868 | 1.0614 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Hite Fred | Director, COO and CFO | 2025-08-21 | 5,076 | A | 213,065 |
| Throdahl Mark C | Director | 2025-05-23 | 8,401 | A | 167,881 |
| Riccitelli Samuel D | Director | 2025-05-23 | 8,401 | A | 20,423 |
| Pelizzon David R | Director | 2025-05-23 | 8,401 | A | 32,948 |
| Dyer George Sinclair Mitchell | Director | 2025-05-23 | 8,401 | A | 13,132 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Blue Trust, Inc. | 2025-09-30 | 92,650 | 5,000 | 18.53 |
| CWM, LLC | 2025-09-30 | 3,000 | 164 | 18.2927 |
| HARBOR CAPITAL ADVISORS, INC. | 2025-09-30 | 1,940,000 | 104,689 | 18.5311 |
| Farther Finance Advisors, LLC | 2025-09-30 | 93 | 5 | 18.6 |
| GAMMA Investing LLC | 2025-09-30 | 1,482 | 80 | 18.525 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Grandeur Peak Global Trust | 2025-07-31 | Investor Class | GPROX | 12,570 | 260,450.4 | 0.2077 |
| Grandeur Peak Global Trust | 2025-07-31 | Institutional Class | GPRIX | 12,570 | 260,450.4 | 0.2077 |
| Grandeur Peak Global Trust | 2025-07-31 | Institutional Class | GPMCX | 8,496 | 176,037.12 | 0.3767 |
| Advisors' Inner Circle Fund III | 2025-07-31 | I Shares | KCXIX | 75 | 1,554 | 0.0006 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2025-07-31 | Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 14,535 | 301,165.2 | 0.0127 |